Compounds > trierucate
Page last updated: 2024-12-11

trierucate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5463075
CHEMBL ID4297655
SCHEMBL ID712083
MeSH IDM0097102

Synonyms (48)

Synonym
LMGL03012438
tg(22:1/22:1/22:1)
tg(22:1(13z)/22:1(13z)/22:1(13z))
1,2,3-tri-(13z-docosenoyl)-glycerol
13-docosenoic acid, 1,2,3-propanetriyl ester, (z,z,z)-
propane-1,2,3-triyl tris((z)-docos-13-enoate)
einecs 220-399-7
erucin, tri-
erucic acid triglyceride
13-docosenoic acid, 1,2,3-propanetriyl ester
glycerol trierucate
1,2,3-propanetriol tri(13-docosenoate)
tri(z-13-docosenoyl)glycerol
trierucin
glyceryl trierucate
trierucate
2,3-bis[[(z)-docos-13-enoyl]oxy]propyl (z)-docos-13-enoate
2752-99-0
1,2,3-tri(cis-13-docosenoyl) glycerol
T1390
glycerol tri-13-docosenoate
i0idq0m20r ,
unii-i0idq0m20r
glyceryl tri(cis-13-docosenoate)
trierucin [inci]
(z)-13-docosenoic acid triglyceride
13-docosenoin, tri-, (z,z,z)-
glyceryl trierucate [who-dd]
glyceryl trierucate [mart.]
glyceryl trierucate [vandf]
13-docosenoic acid, 1,2,3-propanetriyl ester, (13z,13'z,13''z)-
SCHEMBL712083
mfcd00056321
J-016802
1,2,3-propanetriyl ester(z,z,z)-13-docosenoic acid
DB12528
HY-N7055
tri-13(z)-docosenoin
Q15726025
CS-0100518
CHEMBL4297655
F82435
MS-31902
13-docosenoic acid, 1,1',1''-(1,2,3-propanetriyl) ester, (13z,13'z,13''z)-
CAA75299
DTXSID401021942
tg 22:1_22:1_22:1
AKOS040759352
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (2)

PathwayProteinsCompounds
Triacylglycerol Degradation TG(22:1(13Z)/22:1(13Z)/22:1(13Z))511
De Novo Triacylglycerol Biosynthesis TG(22:1(13Z)/22:1(13Z)/22:1(13Z))513

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's3 (37.50)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.98 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
2,4-dinitrophenol
2,4-Dinitrophenol: A toxic dye, chemically related to trinitrophenol (picric acid), used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. (Stedman, 26th ed). dinitrophenol : Members of the class of nitrophenol carrying two nitro substituents.. 2,4-dinitrophenol : A dinitrophenol having the nitro groups at the 2- and 4-positions.		1.9610dinitrophenolallergen;
antiseptic drug;
bacterial xenobiotic metabolite;
geroprotector;
oxidative phosphorylation inhibitor
tristearin
tristearoylglycerol : A triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with stearic acid.		1.9510triacylglycerol 54:0Caenorhabditis elegans metabolite;
plant metabolite
tripalmitin
tripalmitin: structure. tripalmitin : A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by palmitic (hexadecanoic) acid.		1.9510triglyceride
erucic acid
[no description available]		210docosenoic acid
triolein
Triolein: (Z)-9-Octadecenoic acid 1,2,3-propanetriyl ester.. triolein : A triglyceride formed by esterification of the three hydroxy groups of glycerol with oleic acid. Triolein is one of the two components of Lorenzo's oil.		2.8940triglycerideCaenorhabditis elegans metabolite;
plant metabolite
glucagon
Glucagon: A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511). glucagon : A 29-amino acid peptide hormone consisting of His, Ser, Gln, Gly, Thr, Phe, Thr, Ser, Asp, Tyr, Ser, Lys, Tyr, Leu, Asp, Ser, Arg, Arg, Ala, Gln, Asp, Phe, Val, Gln, Trp, Leu, Met, Asn and Thr residues joined in sequence.		1.9610peptide hormone
phosphatidylcholines
Phosphatidylcholines: Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety.		2.07101,2-diacyl-sn-glycero-3-phosphocholine
ConditionIndicatedRelationship StrengthStudiesTrials
Addison Disease and Cerebral Sclerosis
[description not available]		02.6830
Clinically Isolated CNS Demyelinating Syndrome
[description not available]		01.9810
Leukocytopenia
[description not available]		01.9810
Thrombopenia
[description not available]		02.3920
Adrenoleukodystrophy
An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).		14.6830
Demyelinating Diseases
Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.		01.9810
Leukopenia
A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).		01.9810
Thrombocytopenia
A subnormal level of BLOOD PLATELETS.		02.3920